THERESA SEARS: Open Payments
NPI 1982707246 · MAXWELTON, WV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$636 in 35 payments from 9 companies in 2025. Trend: 2023 $1,077 · 2024 $596 · 2025 $636
Food & beverage: $636
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 16 | $216 |
| Janssen Pharmaceuticals, Inc | 4 | $101 |
| Otsuka America Pharmaceutical, Inc. | 4 | $96 |
| E.R. Squibb & Sons, L.L.C. | 3 | $58 |
| Indivior Inc. | 2 | $46 |
| Alkermes, Inc. | 2 | $43 |
| Neurocrine BioSciences, Inc. | 2 | $40 |
| Teva Pharmaceuticals USA, Inc. | 1 | $20 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $16 |
Products named: VRAYLAR, REXULTI, INVEGA SUSTENNA, COBENFY, SUBLOCADE, INGREZZA, SPRAVATO, VIVITROL.
Industry payments across WV — which companies pay providers there.
